MRC2 expression was highly expressed in the tumor group of CHOL, GBM, HNSC, and THCA, whereas lowly expressed in BLCA, CESC, KICH, KIRC, KIRP, LUAD, LUSC, PCPG, PRAD, and UCEC. Here, MRC2 is linked to bladder transitional cell carcinoma.